Upgrade to SI Premium - Free Trial

Acorda Therapeutics (ACOR)

13.21 +1.30 (10.92%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/7/23 *Est.)
- M&A (1/26/16 *Est)

Latest Headlines

Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024 March 25, 2024 4:01 PM - BizWire Form 8-K Acorda Therapeutics, For: Mar 07 March 13, 2024 4:31 PM - SEC Filing Form 8-K Acorda Therapeutics, For: Jan 08 January 11, 2024 8:34 AM - SEC Filing Acorda Therapeutics (ACOR) to Regain Global Commercialization Rights to FAMPYRA by January 2025 January 11, 2024 8:01 AM - StreetInsider Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025 January 11, 2024 8:01 AM - BizWire Full Article List